Akèy › Metiyè › Natural Sciences Managers › Miami, FL
Natural Sciences Managers nan Miami, FL: Salè H-1B
37 aplikasyon kondisyon travay pou okipasyon sa a ak yon sit travay nan Miami, FL. Salè baz medyàn ofri $77,703; mwatye mitan $59,713–$105,000.
Demann (LCA)37
Salè medyan ofri$77,703
Mwatye salè yo$59,713–$105,000
10yèm–90yèm pousantaj$55,306–$129,684
Pa nivo salè
| Nivo revni | Salè medyan |
|---|---|
| Nivo I (antre) | $59,426 |
| Nivo II (kalifye) | $94,474 |
| Nivo III (eksperyans) | $120,000 |
| Nivo IV (plen kompetans) | $165,585 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|---|---|
| University of Miami | 25 | $75,000 |
| Biorasi LLC | 2 | $120,000 |
| D&H National Research Center | 2 | $58,000 |
| Variety Children's Hospital | 1 | $110,000 |
| My Time Inc | 1 | — |
| PPD Development, L.P. | 1 | $130,000 |
| Crystal Lagoons U.S. Corp | 1 | $338,232 |
| The Nature Conservancy | 1 | $129,210 |
| Mas Institute Inc | 1 | $60,000 |
| Pfizer Inc. | 1 | $250,000 |
| P & L Development LLC | 1 | $201,960 |
Tit travay
- Clinical Research Coordinator 19
- Manager, Research Support5
- Clinical Research Coordinator 25
- Manager, Research Data2
- Clinical Trial Manager2
- Clinical Research Rater2
- Sr. Manager Research Support2
- Director, Research Laboratory1
- Manager, Personalized Medicine1
- Clinical Research Coordinator1
- Director, Research Support1
- Clinical Team Manager1
- Sr. Vice President of Intellectual Property and R&D1
- Program Director II1
- Clinical Coordinator and Research Administrator Position1
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).